Coronavirus pandemic response
DIOSynVax is working hard to tackle the current COVID-19 pandemic. Our novel platform technology is developing a significantly accelerated safe vaccine candidate that:

  • Achieves dramatic improvements to CoV protection, avoiding deleterious immunopathology
  • Confers protection against multiple strains of coronaviruses
  • Is compatible with existing vaccine delivery systems for rapid scaling

Read more about our work on the coronavirus here.
COVID-19 coronavirus vaccine: everything you need to know
DIOSynVax's unique vaccine accelerator platform utilises novel high-throughput, computationally generated, immune selected vaccine antigens for broad vaccine protection. Further, our platform targets future threats from these diverse RNA viruses currently circulating in animal reservoirs (see here on how viruses closely related to SARS-CoV-2 threaten to jump into humans).